SPP1 and glaucoma: Several past studies assessed SPP1 levels in POAG and primary angle-closure glaucoma with differential findings.42,43 Further characterization of SPP1 levels in humans with progressive optic nerve damage may help in the decision to escalate medical or surgical treatment.